We recently reported that receptor activator of NF-κB ligand (RANKL) expression induces epithelial mesenchymal transition (EMT) and angiogenesis in HNSCC in vivo and correlates with histological differentiation in human HNSCC specimens18. The gene discussed is TNFSF11; the disease is head and neck squamous cell carcinoma.